PortfolioMetrics

XBI vs. IXJ - ETF Comparison

XBI - SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) provides exposure to the biotechnology sector in the United States, offering a diversified portfolio of mid-cap and small-cap securities. The fund tracks the S&P Biotechnology Select Industry Index, using an equal-weighted methodology to balance assets across all components. This ETF is suitable for investors seeking to fine-tune their exposure to the health care sector or those bullish on biotechnology over the long run.

IXJ - iShares Global Healthcare ETF

The iShares Global Healthcare ETF provides exposure to the global healthcare sector, offering a low-volatility investment opportunity. The fund tracks the S&P Global 1200 / Health Care index, investing in a diversified portfolio of large-cap healthcare companies across developed markets, with a focus on the US and ex-US developed markets. This ETF is suitable for investors seeking to implement a tactical tilt towards healthcare or pursue a sector rotation strategy.

XBIIXJ
Fund NameSPDR S&P Biotech ETFiShares Global Healthcare ETF
Fund ProviderState StreetBlackRock
IndexS&P Biotechnology Select IndustryS&P Global 1200 / Health Care -SEC
Asset ClassEquityEquity
ListingUS-listedUS-listed
Expense Ratio0.35%0.42%
Inception Date2006-01-312001-11-13
Number Of Holdings140113
RegionUnited StatesDeveloped Markets
Investment StyleGrowthBlend
Market CapBlendLarge-Cap
SectorHealthcareHealthcare
LeveragedNon-leveragedNon-leveraged
Invert Comparison

Select Timeframe

Key Metrics

Run the backtest to get the results

Performance Metrics

Run the backtest to get the results

Risk Metrics

Run the backtest to get the results

Detailed Returns

Run the backtest to get the results

Benchmark Comparison

Run the backtest to get the results

Key Metrics

Run the backtest to get the results

Performance Metrics

Run the backtest to get the results

Risk Metrics

Run the backtest to get the results

Detailed Returns

Run the backtest to get the results

Benchmark Comparison

Run the backtest to get the results

Performance Analysis

The performance analysis examines historical data to assess the returns of the investment strategy, including key metrics such as Cumulative returns, End of Year (EoY) returns, and risk-adjusted returns like the Sharpe ratio or the Sortino ratio.

Cumulative Returns

Run the backtest to get the results

End of Year Returns Table

Run the backtest to get the results

End of Year Returns

Run the backtest to get the results

Risk Analysis

The risk analysis refers to an assessment of potential negative events that could lead to a loss of capital. Conducting a risk analysis can help in deciding whether an investment should be made. This is done using risk metrics such as drawdowns, volatility and beta which reflect stakeholders' confidence in the consistency of an investment strategy.

Drawdowns

Run the backtest to get the results

Drawdowns Table

Run the backtest to get the results

Monte Carlo Simulation

The Monte Carlo simulation is a statistical method used to forecast portfolio returns by generating a wide range of potential outcomes through random sampling from historical asset price data. It helps investors assess the potential risk and return of a portfolio under various market conditions. The simulation takes into account the initial investment and optionally simulates cash flow scenarios like fixed contributions, fixed withdrawals, or percentage withdrawals.

IMPORTANT: The forecast generated through Monte Carlo simulations is purely hypothetical and does not guarantee future returns. Investment decisions should be made with consideration of various factors, and past performance is not indicative of future results.

Monte Carlo Metrics

Run the backtest to get the results

Simulated Portfolio Prices

Run the backtest to get the results